DR. KAREN S SLOBOD, MD
Medical Practice in Memphis, TN
License number
Tennessee 24213
Category
Medical Practice
Type
Pediatric Infectious Diseases
Address
Address
332 N Lauderdale St., Memphis, TN 38105
Phone
(901) 495-3006
(901) 495-3842 (Fax)
(901) 495-3842 (Fax)
Professional information
Dr. Karen S Slobod, Memphis TN - MD (Doctor of Medicine)
Specialties:
Pediatric Infectious Disease Medicine
Address:
262 Danny Thomas Pl, Memphis 38105
(901) 495-3842 (Fax)
ST JUDE CHILDRENS RESEARCH HOSPITAL
262 Danny Thomas Pl, Memphis 38105
(901) 495-3300 (Phone), (901) 495-3842 (Fax)
(901) 495-3842 (Fax)
ST JUDE CHILDRENS RESEARCH HOSPITAL
262 Danny Thomas Pl, Memphis 38105
(901) 495-3300 (Phone), (901) 495-3842 (Fax)
Certifications:
Pediatric Infectious Disease Medicine, 2002, Pediatrics, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
McGill University / Faculty of Medicine
Montreal Chldn's Hosp
St Jude
McGill University / Faculty of Medicine
Montreal Chldn's Hosp
St Jude
Preparation And Use Of Viral Vectors For Mixed Envelope Protein Vaccines Against Human Immunodeficiency Viruses
US Patent:
6723558, Apr 20, 2004
Filed:
May 10, 2000
Appl. No.:
09/568105
Inventors:
Julia Hurwitz - Germantown TN
Christopher Coleclough - Germantown TN
Randall Owens - Myersville MD
Karen Slobod - Memphis TN
Christopher Coleclough - Germantown TN
Randall Owens - Myersville MD
Karen Slobod - Memphis TN
Assignee:
St. Jude Childrens Research Hospital - Memphis TN
International Classification:
C12N 1574
US Classification:
4353201, 536 231, 536 232, 4242081, 4242301, 4241601, 4241991, 514 44
Abstract:
Polyenv vaccines are provided that comprise mixtures of at least 4 to about 10,000 different recombinant viruses that each express a different HIV env variant or a portion thereof containing both constant and variable regions, as well as methods of making and using such polyenv vaccines and viruses, including the use of the polyenv vaccine, in live, attenuated or inactivated form, for prophylaxis or treatment of HIV infection. The viral vaccines of the invention are optimally combined with a recombinant HIV env booster, or a recombinant HIV env gene DNA priming or boosting vaccine.
Preparation And Use Of Viral Vectors For Mixed Envelope Protein Immunogenic Composition Against Human Immunodeficiency Viruses
US Patent:
5846546, Dec 8, 1998
Filed:
Jan 23, 1997
Appl. No.:
8/788815
Inventors:
Julia Hurwitz - Germantown TN
Karen Slobod - Memphis TN
Karen Slobod - Memphis TN
Assignee:
St. Jude Children's Research Hospital - Memphis TN
International Classification:
A61K 39295, A61K 3912, A61K 3921, A01N 4304
US Classification:
4242021
Abstract:
Polyenv immunogenic composition are provided that comprise mixtures of at least 4 different recombinant viruses that each express a different HIV env variant or a portion thereof containing both constant and variable regions, as well as methods of making and using such polyenv immunogenic composition and viruses. The immunogenic composition of the invention are optimally combined with a recombinant HIV env booster, or a recombinant HIV env gene DNA priming or boosting vaccine.
Use Of Sendai Virus As A Human Parainfluenza Vaccine
US Patent:
2006011, May 25, 2006
Filed:
Jan 12, 2004
Appl. No.:
10/540367
Inventors:
Julia Hurwitz - Germantown TN, US
Christopher Coleclough - Germantown TN, US
Karen Slobod - Memphis TN, US
Allen Portner - Bartlett TN, US
Christopher Coleclough - Germantown TN, US
Karen Slobod - Memphis TN, US
Allen Portner - Bartlett TN, US
International Classification:
C12Q 1/70, C12Q 1/68
US Classification:
435006000, 435005000
Abstract:
Immunogenic compositions to protect against human parainfluenza (hPIV) virus infection are provided. The compositions comprise an unmodified Sendai virus that can be safely administered to human subjects, particularly young children, to protect against symptoms and health risks associated with hPIV infection.